T Takata Selected Research

T Takata Research Topics

Disease

12	Neoplasms (Cancer) 11/2020 - 04/2000
5	Carcinogenesis 10/2013 - 04/2000
5	Inflammation (Inflammations) 10/2013 - 07/2001
4	Squamous Cell Carcinoma of Head and Neck 10/2013 - 03/2000
3	Neoplasm Metastasis (Metastasis) 10/2013 - 11/2006
3	Ameloblastoma 02/2009 - 04/2000
3	Odontogenic Tumors (Dental Tissue Neoplasm) 02/2009 - 04/2000
3	Carcinoma (Carcinomatosis) 02/2009 - 04/2000
2	Periodontitis 02/2014 - 10/2013
2	Bone Resorption 02/2014 - 09/2004
2	Root Resorption 12/2011 - 02/2010
2	Periodontal Diseases (Periodontal Disease) 02/2010 - 07/2001
2	Mouth Neoplasms (Oral Cancer) 01/2008 - 11/2006
2	Calcifying Odontogenic Cyst 08/2000 - 04/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2015
1	Insulin Resistance 05/2015
1	Hyperglycemia 05/2015
1	Dyslipidemias (Dyslipidemia) 05/2015
1	Infections 02/2014
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2009
1	Giant Cell Granuloma (Peripheral Giant Cell Granuloma) 01/2006
1	Craniopharyngioma (Craniopharyngiomas) 12/2004
1	Cataract (Cataracts) 03/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2003
1	Xanthomatosis (Xanthoma) 06/2003
1	Ankylosis 12/2002
1	Fibroma (Fibromatosis) 05/2002
1	Neuroblastoma 11/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2001
1	Occupational Injuries 01/2001
1	Alzheimer Disease (Alzheimer's Disease) 12/2000
1	Odontoma 08/2000
1	Lead Poisoning (Poisoning, Lead) 01/2000

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2006 - 04/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 07/2001
2	IntegrinsIBA 11/2018 - 10/2007
2	LactoferrinIBA 02/2014 - 10/2013
2	Peptide Hydrolases (Proteases)FDA Link 02/2010 - 08/2000
2	beta CateninIBA 02/2009 - 12/2004
2	PeriostinIBA 10/2007 - 11/2006
2	Matrix Metalloproteinase 20IBA 08/2000 - 04/2000
1	Deuterium Oxide (Heavy Water)IBA 11/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2018
1	TRO-A0001IBA 11/2015
1	Rotaxanes (Rotaxane)IBA 11/2015
1	Atorvastatin (Lipitor)FDA Link 05/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	Advanced Glycation End ProductsIBA 05/2015
1	AdiponectinIBA 05/2015
1	AdipokinesIBA 05/2015
1	PD 173074IBA 10/2013
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 10/2013
1	Cadherins (E-Cadherin)IBA 10/2013
1	Oncogene Proteins (Oncogene Protein)IBA 10/2013
1	CollagenIBA 02/2010
1	LipopolysaccharidesIBA 02/2010
1	ParaffinIBA 02/2009
1	Formaldehyde (Formol)FDA Link 02/2009
1	Indicators and Reagents (Reagents)IBA 01/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2008
1	Vascular Endothelial Growth Factor CIBA 01/2008
1	Messenger RNA (mRNA)IBA 11/2006
1	Dinoprostone (PGE2)FDA Link 09/2004
1	Crystallins (Crystallin)IBA 03/2004
1	alpha-Crystallin A ChainIBA 03/2004
1	SurvivinIBA 11/2003
1	VX (EDIM)IBA 06/2003
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2003
1	MineralsIBA 12/2002
1	Tumor Viral Antigens (Large T Antigen)IBA 05/2002
1	lembehyne AIBA 11/2001
1	Phosphotransferases (Kinase)IBA 10/2001
1	F-Box ProteinsIBA 10/2001
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2001
1	CytokinesIBA 07/2001
1	Caspase 3 (Caspase-3)IBA 01/2001
1	Glucose (Dextrose)FDA LinkGeneric 12/2000
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2000
1	Amyloid (Amyloid Fibrils)IBA 08/2000
1	Monoclonal AntibodiesIBA 08/2000
1	AmelogeninIBA 04/2000
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2000
1	AntibodiesIBA 04/2000
1	tuftelin (enamelin)IBA 04/2000
1	amsonic acid (DAS)IBA 04/2000
1	Proteasome InhibitorsIBA 03/2000
1	lactacystinIBA 03/2000
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2000
1	Aminolevulinic Acid (Levulan)FDA Link 01/2000

Therapy/Procedure

1	Boron Neutron Capture Therapy 11/2020
1	Telescopes 11/2020
1	Oral Administration 02/2014
1	Tooth Movement Techniques 10/2013
1	Tooth Replantation 12/2011
1	Ultrasonic Therapy 12/2011
1	Aftercare (After-Treatment) 01/2006
1	Secondary Prevention 01/2001
1	Therapeutics 01/2001